Cargando…
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study
BACKGROUND: Timely stratification of Crohn's disease (CD) is essential for patients' management. The use of noninvasive accurate biomarkers is key to monitor treatment and to pursue mucosal healing, the ultimate treatment endpoint in CD. OBJECTIVE: We aimed to evaluate the performance of r...
Autores principales: | Magro, Fernando, Estevinho, Maria Manuela, Catalano, Gaia, Patita, Marta, Arroja, Bruno, Lago, Paula, Rosa, Isadora, Tavares de Sousa, Helena, Ministro, Paula, Mocanu, Irina, Vieira, Ana, Castela, Joana, Moleiro, Joana, Roseira, Joana, Cancela, Eugénia, Sousa, Paula, Portela, Francisco, Correia, Luís, Moreira, Paula, Santiago, Mafalda, Dias, Sandra, Afonso, Joana, Danese, Silvio, Peyrin‐Biroulet, Laurent, Dias, Cláudia Camila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337732/ https://www.ncbi.nlm.nih.gov/pubmed/37318072 http://dx.doi.org/10.1002/ueg2.12420 |
Ejemplares similares
-
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2021) -
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2023) -
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2022) -
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
por: Caron, Bénédicte, et al.
Publicado: (2022) -
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023)